News | Artificial Intelligence | July 07, 2021

Combined technology solution to accelerate radiomics research and clinical trial outcomes

Flywheel, a leading cloud-scale informatics platform for medical research and collaboration, and HealthMyne, a pioneer in applied radiomics, announced today a partnership that will combine the companies’ technologies to accelerate radiomics research and advance clinical trials outcomes for life sciences and clinical research clients.

July 7, 2021 — Flywheel, a leading cloud-scale informatics platform for medical research and collaboration, and HealthMyne, a pioneer in applied radiomics, announced today a partnership that will combine the companies’ technologies to accelerate radiomics research and advance clinical trials outcomes for life sciences and clinical research clients.

Combining Flywheel’s comprehensive informatics platform with HealthMyne’s artificial-intelligence-enabled radiomics solutions provides an innovative approach for clinical trials and oncology research. The combined platform features an open, extensible architecture to facilitate the automation and streamlining of data curation, quantitative image analysis and radiomic computation.

Flywheel provides an end-to-end research workflow solution that helps life sciences, clinical and academic researchers transform productivity, curation, and collaboration with medical research data. HealthMyne’s solution performs radiomic analysis, which is the process of extracting and converting quantitative descriptors of tumor structure and lesion characteristics into mineable data, to support emerging therapy development and response assessment approaches.

Together, the combined technologies will enable life sciences companies and researchers to gain a deeper understanding of tumor or lesion response to a specific therapy, acquire new insights to enrich clinical trials and leverage novel data to better personalize treatments for the best patient outcomes.

“By combining medical imaging and genomics data on a single cloud-scalable platform, researchers can now enter uncharted territory in healthcare innovation - streamlined, enterprise-scale radiomics research. HealthMyne's innovative algorithms on Flywheel's platform will not only provide valuable insights in clinical trials but also accelerate the development of new discoveries in cancer research," said Jim Olson, CEO, Flywheel.

“Leveraging Flywheel’s bioinformatics platform coupled with HealthMyne’s ability to compute advanced imaging analytics and reveal radiomic insights further enhances the understanding of disease progression, treatment response and clinical trial outcomes,” said Rose Higgins, CEO, HealthMyne. “This partnership will enable our clients to fully realize the value of their imaging pipeline to help tackle complex diseases such as cancer.”

For more information: www.healthmyne.com


Related Content

News | Artificial Intelligence

December 2, 2022 — emtelligent, a leader in the development of clinical-grade natural language processing (NLP) software ...

Time December 02, 2022
arrow
News | Artificial Intelligence

December 1, 2022 — VIDA Diagnostics, Inc. (VIDA), the leader in imaging intelligence, has announced the availability of ...

Time December 01, 2022
arrow
News | Artificial Intelligence

December 1, 2022 — Annalise.ai and Nuance announced that the global medical imaging AI company has joined the Nuance ...

Time December 01, 2022
arrow
News | Artificial Intelligence

December 1, 2022 — At the 2022 Radiological Society of North America (RSNA) Annual Meeting, Peter R. Eby, MD, of ...

Time December 01, 2022
arrow
Feature | RSNA | Christine Book

November 30, 2022 — On the fourth day of RSNA 2022, inside Chicago’s McCormick Place, an estimated 260 separate events ...

Time December 01, 2022
arrow
News | Artificial Intelligence

November 30, 2022 — Ziosoft, a pioneer in 3D/4D AI medical visualization, is introducing its newest software for its ...

Time November 30, 2022
arrow
News | Artificial Intelligence

November 29, 2022 — Researchers have developed a deep learning model that uses a single chest X-ray to predict the 10 ...

Time November 29, 2022
arrow
News | PACS

November 28, 2022 — At this week’s Radiological Society of North America (RSNA) annual meeting (November 27 – December 1 ...

Time November 28, 2022
arrow
News | Mammography

November 28, 2022 — The Radiological Society of North America (RSNA) has announced the launch of the RSNA Screening ...

Time November 28, 2022
arrow
News | Artificial Intelligence

November 28, 2022 — Carestream Health will demonstrate the value and impact of artificial intelligence (AI) in radiology ...

Time November 28, 2022
arrow
Subscribe Now